News Shortcuts from BMJPG journals

Adalimumab maintains remission in Crohn's disease

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7615.325-b (Published 16 August 2007) Cite this as: BMJ 2007;335:325

Patients with moderate to severe Crohn's disease who had achieved remission after a four week regimen of the cytokine inhibitor adalimumab (CLASSIC I trial) went on to a placebo controlled trial …

View Full Text

Sign in

Log in through your institution

Subscribe